Understanding how certain cells help heal bone fractures
Fate and Regulation of Fracture-induced Prx1 Cells
This study is looking at how certain cells in your body help heal broken bones, especially for people whose fractures aren't healing well, to find better and less invasive treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rush University Medical Center NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10649689 on NIH RePORTER |
What this research studies
This research investigates the cellular and molecular mechanisms involved in the healing process of bone fractures, particularly focusing on a specific type of cell known as Prx1+ cells. By studying how these cells contribute to fracture repair, the research aims to identify new therapeutic targets for treating patients with non-unions, a condition where fractures fail to heal properly. The approach includes examining the behavior of these cells during the healing process and their interactions with other molecules that promote repair. The ultimate goal is to develop alternative treatments that are less invasive and more effective than current methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults suffering from non-union fractures, particularly those who have not responded well to traditional treatments.
Not a fit: Patients with fractures that are healing normally or those who do not have bone-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that significantly improve healing outcomes for patients with difficult-to-treat bone fractures.
How similar studies have performed: Other research has shown promise in understanding cellular mechanisms of bone healing, suggesting that this approach could yield valuable insights and advancements.
Where this research is happening
Chicago, United States
- Rush University Medical Center — Chicago, United States (Active)
Researchers
- Principal investigator: Spagnoli, Anna — Rush University Medical Center
- Study coordinator: Spagnoli, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.